Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 55-62

  McCarron, Mark ^a,b   Reen, Denis J ^a,b  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; 2,3 BIS (PALMITOYLOXY) 2 PROPYL N PALMITOYL CYSTEINYLSERINE; 2,3-BIS-(PALMITOYLOXY)-2-PROPYL-N-PALMITOYL-CYSTEINYLSERINE; DIPEPTIDE; IMMUNOLOGICAL ADJUVANT; LIGAND; LIPOPROTEIN; TLR2 PROTEIN, HUMAN; TLR5 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIVISION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FETUS BLOOD; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SYNTHESIS;

ADJUVANTS, IMMUNOLOGIC; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DIPEPTIDES; FETAL BLOOD; FLAGELLIN; HUMANS; IMMUNITY, CELLULAR; INFANT, NEWBORN; LIGANDS; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 5;

EID: 59849094301     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.55     Document Type: Article

References (55)

1. Adkins, B. 1999. T-cell function in newborn mice and humans. Immunol. Today 20: 330-335.
2. Marshall-Clarke, S., D. Reen, L. Tasker, and J. Hassan. 2000. Neonatal immunity: how well has it grown up? Immunol. Today 21: 35-41.
3. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4: 553-564.
4. Ehreth, J. 2003. The value of vaccination: a global perspective. Vaccine 21: 4105-4117.
5. Lambert, P. H., M. Liu, and C. A. Siegrist. 2005. Can successful vaccines teach us how to induce efficient protective immune responses? Nat. Med. 11: S54-S62.
6. Siegrist, C. A. 2001. Neonatal and early life vaccinology. Vaccine 19: 3331-3346.
7. + memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection. Int. Immunol. 18: 249-257.
8. + T cell vaccine design. Expert Opin. Biol. Ther. 5: 263-271.
9. Hermann, E., C. Truyens, C. Alonso-Vega, J. Even, P. Rodriguez, A. Berthe, E. Gonzalez-Merino, F. Torrico, and Y. Carlier. 2002. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 100: 2153-2158.
10. + T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 111: 1747-1755.
11. Aguilar, J. C., and E. G. Rodriguez. 2007. Vaccine adjuvants revisited. Vaccine 25: 3752-3762.
12. Kanzler, H., F. J. Barrat, E. M. Hessel, and R. L. Coffman. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13: 552-559.
13. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
14. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54(Pt 1): 1-13.
15. Kabelitz, D. 2007. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19: 39-45.
16. Komai-Koma, M., L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew. 2004. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 101: 3029-3034.
17. + T cells. J. Immunol. 175: 1551-1557.
18. + T regulatory cells. J. Immunol. 175: 8051-8059.
19. + regulatory T cell function. Science 309: 1380-1384.
20. Sutmuller, R. P. M., M. H. den Brok, M. Kramer, E. J. Bennink, L. W. Toonen, B. J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and G. J. Adema. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116: 485-494.
21. Wesch, D., S. Beetz, H. H. Oberg, M. Marget, K. Krengel, and D. Kabelitz. 2006. Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes. J. Immunol. 176: 1348-1354.
22. Sobek, V., N. Birkner, I. Falk, A. Wurch, C. J. Kirschning, H. Wagner, R. Wallich, M. C. Lamers, and M. M. Simon. 2004. Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res. Ther. 6: R433-R446.
23. Cottalorda, A., C. Verschelde, A. Marcais, M. Tomkowiak, P. Musette, S. Uematsu, S. Akira, J. Marvel, and N. Bonnefoy-Berard. 2006. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur. J. Immunol. 36: 1684-1693.
24. + T lymphocytes express TLR3 as a functional coreceptor. J. Immunol. 177: 8708-8713.
25. Mescher, M. F., J. M. Curtsinger, P. Agarwal, K. A. Casey, M. Gerner, C. D. Hammerbeck, F. Popescu, and Z. Xiao. 2006. Signals required for programming effector and memory development by CD8 T cells. Immunol. Rev. 211: 81-92.
26. D'Arena, G., P. Musto, N. Cascavilla, G. Di Giorgio, S. Fusilli, F. Zendoli, and M. Carotenuto. 1998. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 83: 197-203.
27. Chatila, T. A., D. H. Schwartz, R. Miller, and R. S. Geha. 1987. Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation. Clin. Immunol. Immunopathol. 44: 235-247.
28. Trickett, A., and Y. L. Kwan. 2003. T cell stimulation and expansion using anti-CD3/CD28 beads. J. Immunol. Methods 275: 251-255.
29. Brenchley, J. M., D. C. Douek, D. R. Ambrozak, M. Chatterji, M. R. Betts, L. S. Davis, and R. A. Koup. 2002. Expansion of activated human naive T-cells precedes effector function. Clin. Exp. Immunol. 130: 432-440.
30. D'Souza, W. N., and L. Lefrançois. 2003. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171: 5727-5735.
31. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308.
32. Kornbluth, R. S., and G. W. Stone. 2006. Immunostimulatory combinations: designing the next generation of vaccine adjuvants. J. Leukocyte Biol. 80: 1084-1102.
33. Kokkinopoulos, I., W. J. Jordan, and M. A. Ritter. 2005. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol. Immunol. 42: 957-968.
34. Ye, Z., and Y. H. Gan. 2007. Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. J. Biol. Chem. 282: 4479-4484.
35. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411.
36. + T cell survival. J. Immunol. 172: 6065-6073.
37. + T cell. Int. Immunol. 19: 193-201.
38. Means, T. K., F. Hayashi, K. D. Smith, A. Aderem, and A. D. Luster. 2003. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J. Immunol. 170: 5165-5175.
39. Mestas, J., and C. C. W. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172: 2731-2738.
40. + T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 180: 1886-1894.
41. Marsland, B. J., C. Nembrini, K. Grun, R. Reissmann, M. Kurrer, C. Leipner, and M. Kopf. 2007. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-θ signaling and promote autoimmune myocarditis. J. Immunol. 178: 3466-3473.
42. + T cells and enables CpG oligodeoxynucleotide- mediated costimulation. Immunity 25: 783-793.
43. Babu, S., C. P. Blauvelt, V. Kumaraswami, and T. B. Nutman. 2006. Cutting edge: Diminished T cell TLR expression and function modulates the immune response in human filarial infection. J. Immunol. 176: 3885-3889.
44. Dolganiuc, A., C. Garcia, K. Kodys, and G. Szabo. 2006. Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J. Gastroenterol. 12: 1198-1204.
45. + T cells more susceptible to productive infection with X4 and R5 HIV-type 1. J. Immunol. 179: 4357-4366.
46. Zanin-Zhorov, A., G. Nussbaum, S. Franitza, I. R. Cohen, and O. Lider. 2003. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 17: 1567-1569.
47. Nussbaum, G., A. Zanin-Zhorov, F. Quintana, O. Lider, and I. R. Cohen. 2006. Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis. Int. Immunol. 18: 1413-1419.
48. + memory T cells. Nature 441: 890-893.
49. Hume, D. A., D. M. Underhill, M. J. Sweet, A. O. Ozinsky, F. Y. Liew, and A. Aderem. 2001. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via Toll-like receptors exhibit a sustained and additive activation state. BMC Immunol. 2: 11.
50. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776.
51. Marshall, J. D., D. S. Heeke, M. L. Gesner, B. Livingston, and G. Van Nest. 2007. Negative regulation of TLR9-mediated IFN-α induction by a small-molecule, synthetic TLR7 ligand. J. Leukocyte Biol. 82: 497-508.
52. Macagno, A., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 28: 227-233.
53. Komoriya, K., N. Shibano, T. Higano, N. Azuma, S. Yamaguchi, and S. I. Aizawa. 1999. Flagellar proteins and type III-exported virulence factors are the predominant proteins secreted into the culture media of Salmonella typhimurium. Mol. Microbiol. 34: 767-779.
54. Subramanian, N., and A. Qadri. 2006. Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella. Nat. Immunol. 7: 583-589.
55. Kaufmann, S. H. 2006. Envisioning future strategies for vaccination against tuberculosis. Nat. Rev. Immunol. 6: 699-704.